Adipose tissue growth and regression are regulated by angiopoietin-1

被引:50
作者
Dallabrida, SM
Zurakowski, D
Shih, SC
Smith, LE
Folkman, J
Moulton, KS
Rupnick, MA
机构
[1] Childrens Hosp, Div Surg Res, Boston, MA 02115 USA
[2] Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA
[3] Childrens Hosp, Dept Biostat, Boston, MA 02115 USA
[4] Childrens Hosp, Dept Opthalmol, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA
[6] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
关键词
adipose tissue; angiogenesis; angiopoietin-1; angiopoietin-2; Tie2; vascular maturation; leptin; TNP-470;
D O I
10.1016/j.bbrc.2003.10.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Adipose tissue is unique in its plasticity, capacity for vascular remodeling, and susceptibility to angiogenesis inhibitors. We hypothesize that these characteristics are enabled by maintaining relatively immature adipose vessels to facilitate vascular/tissue remodeling. We examined the vascular maturation regulators, angiopoietin-1, angiopoietin-2, and tie2 receptor, under different weight-modifying conditions. Adipocytes expressed angiopoietin-1, while adipose endothelial cells expressed angiopoietin-2 and tie2. Adipose tissue growth/regression were associated with decreased angiopoietin-1 mRNA and protein, and tie2 phosphorylation. Angiopoietin-2 and tie2 mRNA levels were stable. Angiopoietin-1 mRNA levels inversely correlated with the rates of change in body weight, independent of the direction (weight gain, loss) or etiology (TNP-470, leptin, and diet restriction) of the weight shift. Obese mice injected with ang1/pcDNA had reduced rates of weight gain and fat pad weights, regardless of the route of plasmid administration (subcutaneous, intramuscular, and intravenous). Thus, angiopoietin-1 may regulate adipose tissue growth, suggesting that vascular maturation alters tissue plasticity. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:563 / 571
页数:9
相关论文
共 35 条
[1]   Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways [J].
Arbiser, JL ;
Moses, MA ;
Fernandez, CA ;
Ghiso, N ;
Cao, YH ;
Klauber, N ;
Frank, D ;
Brownlee, M ;
Flynn, E ;
Parangi, S ;
Byers, HR ;
Folkman, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (03) :861-866
[2]  
BALDWIN HS, 1994, DEVELOPMENT, V120, P2539
[3]   Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma [J].
Brown, LF ;
Dezube, BJ ;
Tognazzi, K ;
Dvorak, HF ;
Yancopoulos, GD .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (06) :2179-2183
[4]   Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization [J].
Chae, JK ;
Kim, I ;
Lim, ST ;
Chung, MJ ;
Kim, WH ;
Kim, HG ;
Ko, JK ;
Koh, GY .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (12) :2573-2578
[5]   Leptin induces angiopoietin-2 expression in adipose tissues [J].
Cohen, B ;
Barkan, D ;
Levy, Y ;
Goldberg, I ;
Fridman, E ;
Kopolovic, J ;
Rubinstein, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (11) :7697-7700
[6]   Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [J].
Davis, S ;
Aldrich, TH ;
Jones, PF ;
Acheson, A ;
Compton, DL ;
Jain, V ;
Ryan, TE ;
Bruno, J ;
Radziejewski, C ;
Maisonpierre, PC ;
Yancopoulos, GD .
CELL, 1996, 87 (07) :1161-1169
[7]  
DUMONT DJ, 1992, ONCOGENE, V7, P1471
[8]   DOMINANT-NEGATIVE AND TARGETED NULL MUTATIONS IN THE ENDOTHELIAL RECEPTOR TYROSINE KINASE, TEK, REVEAL A CRITICAL ROLE IN VASCULOGENESIS OF THE EMBRYO [J].
DUMONT, DJ ;
GRADWOHL, G ;
FONG, GH ;
PURI, MC ;
GERTSENSTEIN, M ;
AUERBACH, A ;
BREITMAN, ML .
GENES & DEVELOPMENT, 1994, 8 (16) :1897-1909
[9]   Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia [J].
Enholm, B ;
Paavonen, K ;
Ristimaki, A ;
Kumar, V ;
Gunji, Y ;
Klefstrom, J ;
Kivinen, L ;
Laiho, M ;
Olofsson, B ;
Joukov, V ;
Eriksson, U ;
Alitalo, K .
ONCOGENE, 1997, 14 (20) :2475-2483
[10]   ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31